Medley Genomics looks to engineer cancer treatment, one tumor at a time

ACTIONABLE DATA: From left, Niru Chennagiri, director of informatics at Medley Genomics, and Patrice Milos, CEO, review notes on genetic information at the company’s Providence office. 
 / PBN PHOTO/RUPERT WHITELEY
ACTIONABLE DATA: From left, Niru Chennagiri, director of informatics at Medley Genomics, and Patrice Milos, CEO, review notes on genetic information at the company’s Providence office. 
 / PBN PHOTO/RUPERT WHITELEY
Innovative Companies | Biotechnology and Life Sciences We’ve all heard of data analytics. But what if this data could be used to treat what may well be the biggest medical beast of our time, cancer? Looking at tumors’ unique, individual composition to find information leading to lasting treatment is the work of Medley Genomics of…

Want More Free?

To access 2 more articles, please log in or register for free.

Registered users get access to a limited number of free articles every month.

Register Now

Already registered? Login to access more free articles.

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -